4//SEC Filing
Torres John D 4
Accession 0001127602-24-022439
CIK 0001069202other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 3:29 PM ET
Size
26.0 KB
Accession
0001127602-24-022439
Insider Transaction Report
Form 4
Torres John D
EVP, Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock, Par Value $0.01 Per Share
2024-08-16$278.00/sh+3,334$926,852→ 14,905 total - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$570.34/sh−1,892$1,079,083→ 9,060 total - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$573.38/sh−529$303,318→ 4,812 total - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$574.06/sh−100$57,406→ 4,712 total - Exercise/Conversion
Non-qualified Stock Appreciation Right
2024-08-16−3,334→ 0 totalExercise: $278.00From: 2021-12-11Exp: 2027-12-11→ Common Stock, Par Value $0.01 Per Share (3,334 underlying) - Exercise/Conversion
Common Stock, Par Value $0.01 Per Share
2024-08-16$259.56/sh+1,103$286,295→ 11,571 total - Disposition to Issuer
Common Stock, Par Value $0.01 Per Share
2024-08-16$577.67/sh−735$424,587→ 14,170 total - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$569.37/sh−932$530,653→ 10,952 total - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$571.24/sh−2,275$1,299,571→ 6,785 total - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$575.95/sh−44$25,342→ 4,668 total - Exercise/Conversion
Non-qualified Stock Appreciation Right
2024-08-16−1,103→ 2,207 totalExercise: $259.56From: 2023-12-09Exp: 2029-12-09→ Common Stock, Par Value $0.01 Per Share (1,103 underlying) - Sale
Common Stock, Par Value $0.01 Per Share
2024-08-16$572.36/sh−1,444$826,488→ 5,341 total - Disposition to Issuer
Common Stock, Par Value $0.01 Per Share
2024-08-16$577.67/sh−2,286$1,320,554→ 11,884 total
Footnotes (8)
- [F1]Reflects a weighted average sale price of $569.37 at prices ranging from $568.810 to $569.630 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]Reflects a weighted average sale price of $570.34 at prices ranging from $569.910 to $570.780 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]Reflects a weighted average sale price of $571.24 at prices ranging from $570.960 to $571.805 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]Reflects a weighted average sale price of $572.36 at prices ranging from $572.000 to $572.820 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F5]Reflects a weighted average sale price of $573.38 at prices ranging from $573.000 to $573.950 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F6]Reflects a weighted average sale price of $575.95 at prices ranging from $575.930 to $576.135 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F7]One third of the Stock Appreciation Rights became exercisable on 12/09/2023 and each year thereafter. The entire grant will become fully exercisable on 12/09/2025.
- [F8]One third of the Stock Appreciation Rights became exercisable on 12/11/2021 and each year thereafter. The entire grant became fully exercisable on 12/11/2023.
Documents
Issuer
LENNOX INTERNATIONAL INC
CIK 0001069202
Entity typeother
Related Parties
1- filerCIK 0001296605
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 3:29 PM ET
- Size
- 26.0 KB